Janssen-Cilag International NV announced IONSYS (fentanyl iontophoretic transdermal system), a new needle-free system ...
January 29, 2008 - The Medicines Company received the European Commission�s authorization of an expanded use for ...
January 29, 2008 � A novel treatment for blood clots in the legs, in which injecting or �lacing� the clot with a ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
Power Medical Interventions Inc. said the FDA cleared its 510(k) application for marketing its intelligent iDrive ...
January 29, 2008 - Edwards Lifesciences Corp. received conditional approval from the FDA for the addition of the ...
Terumo Interventional Systems offers the AZUR Peripheral HydroCoil Embolization System for the occlusion of blood vessels, vascular malformations and aneurysms, extending its interventional device portfolio.
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Cheetah Medical Inc. said the FDA cleared for marketing the Reliant, a portable cardiac output monitor that provides a noninvasive window to cardiac and hemodynamic function.
January 28, 2008 - Arbor Surgical Technologies Inc. closed a $20 million dollar Series C financing round led by ...
MEDecision Inc. introduced Alineo, a collaborative healthcare management platform for addressing case management, disease management and utilization management.
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
January 28, 2008 - Inverness Medical Innovations will acquire Matria Healthcare, Inc. for approximately $1.18 billion, consisting of approximately $900 million to acquire the Matria shares of common stock and assumption of approximately $280 million of Matria's indebtedness outstanding, which will further Inverness' approach of bringing its proprietary diagnostic products into the home.
BD Diagnostics said it received clearance from the FDA for the BD GeneOhm StaphSR assay, which the company says is the first test to rapidly and simultaneously identify two deadly healthcare-associated infections (HAIs) - Staphylococcus aureus and Methicillin-resistant Staphylococcus aureus (MRSA) - from patients with positive blood cultures.
January 28, 2008 - Toshiba America Medical Systems Inc. said today the FDA cleared the new open-bore 1.5T Vantage Titan ...
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
The FDA granted Ethicon Inc. an expanded indication for EVICEL Fibrin Sealant (Human), which is one of the first fibrin sealants available as an adjunct to hemostasis for use in surgery, when control of bleeding by standard surgical techniques is ineffective or impractical.
January 28, 2008 – Medtronic Inc. has launched a clinical trial to confirm the safety and efficacy of the Medtronic ...
Monitoring system maker Mennen Medical said an additional monitor, the VitaLogik 4000 Series, will soon be available for ...